164 related articles for article (PubMed ID: 22123235)
21. [Diabetes, insulin, insulin analogues, and cancer].
Müssig K; Staiger H; Kantartzis K; Fritsche A; Kanz L; Häring HU
Dtsch Med Wochenschr; 2010 May; 135(18):924-9. PubMed ID: 20425680
[TBL] [Abstract][Full Text] [Related]
22. PASSCLAIM--body weight regulation, insulin sensitivity and diabetes risk.
Riccardi G; Aggett P; Brighenti F; Delzenne N; Frayn K; Nieuwenhuizen A; Pannemans D; Theis S; Tuijtelaars S; Vessby B
Eur J Nutr; 2004 Jun; 43 Suppl 2():II7-II46. PubMed ID: 15221353
[TBL] [Abstract][Full Text] [Related]
23. Occupation and cancer - follow-up of 15 million people in five Nordic countries.
Pukkala E; Martinsen JI; Lynge E; Gunnarsdottir HK; Sparén P; Tryggvadottir L; Weiderpass E; Kjaerheim K
Acta Oncol; 2009; 48(5):646-790. PubMed ID: 19925375
[TBL] [Abstract][Full Text] [Related]
24. [Metabolic risk during antipsychotic treatment in patients with schizophrenia].
Rzewuska M
Psychiatr Pol; 2007; 41(4):457-72. PubMed ID: 18046977
[TBL] [Abstract][Full Text] [Related]
25. The metabolic syndrome and chronic kidney disease.
Peralta CA; Kurella M; Lo JC; Chertow GM
Curr Opin Nephrol Hypertens; 2006 Jul; 15(4):361-5. PubMed ID: 16775449
[TBL] [Abstract][Full Text] [Related]
26. Is liver disease a threat to patients with metabolic disorders?
Marchesini G; Forlani G; Bugianesi E
Ann Med; 2005; 37(5):333-46. PubMed ID: 16179269
[TBL] [Abstract][Full Text] [Related]
27. Obesity, energy balance, and cancer: a mechanistic perspective.
Hursting SD
Cancer Treat Res; 2014; 159():21-33. PubMed ID: 24114472
[TBL] [Abstract][Full Text] [Related]
28. Obesity, insulin resistance and cancer risk.
Jee SH; Kim HJ; Lee J
Yonsei Med J; 2005 Aug; 46(4):449-55. PubMed ID: 16127767
[TBL] [Abstract][Full Text] [Related]
29. Increased risk of metabolic syndrome, diabetes mellitus, and cardiovascular disease in men receiving androgen deprivation therapy for prostate cancer.
Kintzel PE; Chase SL; Schultz LM; O'Rourke TJ
Pharmacotherapy; 2008 Dec; 28(12):1511-22. PubMed ID: 19025432
[TBL] [Abstract][Full Text] [Related]
30. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z
Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948
[TBL] [Abstract][Full Text] [Related]
31. Hepatitis C and diabetes: one treatment for two diseases?
Pattullo V; Heathcote J
Liver Int; 2010 Mar; 30(3):356-64. PubMed ID: 20040049
[TBL] [Abstract][Full Text] [Related]
32. Metabolic risk during antipsychotic treatment.
Newcomer JW
Clin Ther; 2004 Dec; 26(12):1936-46. PubMed ID: 15823759
[TBL] [Abstract][Full Text] [Related]
33. [Cardiovascular risk factors and prevention in women: similarities and differences].
Sclavo M
Ital Heart J Suppl; 2001 Feb; 2(2):125-41. PubMed ID: 11255880
[TBL] [Abstract][Full Text] [Related]
34. Associations of sedentary lifestyle, obesity, smoking, alcohol use, and diabetes with the risk of colorectal cancer.
Le Marchand L; Wilkens LR; Kolonel LN; Hankin JH; Lyu LC
Cancer Res; 1997 Nov; 57(21):4787-94. PubMed ID: 9354440
[TBL] [Abstract][Full Text] [Related]
35. Metabolic syndrome and the risk of prostate cancer in Finnish men: a population-based study.
Laukkanen JA; Laaksonen DE; Niskanen L; Pukkala E; Hakkarainen A; Salonen JT
Cancer Epidemiol Biomarkers Prev; 2004 Oct; 13(10):1646-50. PubMed ID: 15466982
[TBL] [Abstract][Full Text] [Related]
36. Obesity and gastrointestinal cancer.
Donohoe CL; Pidgeon GP; Lysaght J; Reynolds JV
Br J Surg; 2010 May; 97(5):628-42. PubMed ID: 20306531
[TBL] [Abstract][Full Text] [Related]
37. Lifestyle modification and endothelial function in obese subjects.
Hamdy O
Expert Rev Cardiovasc Ther; 2005 Mar; 3(2):231-41. PubMed ID: 15853597
[TBL] [Abstract][Full Text] [Related]
38. Prebiotic effects: metabolic and health benefits.
Roberfroid M; Gibson GR; Hoyles L; McCartney AL; Rastall R; Rowland I; Wolvers D; Watzl B; Szajewska H; Stahl B; Guarner F; Respondek F; Whelan K; Coxam V; Davicco MJ; Léotoing L; Wittrant Y; Delzenne NM; Cani PD; Neyrinck AM; Meheust A
Br J Nutr; 2010 Aug; 104 Suppl 2():S1-63. PubMed ID: 20920376
[TBL] [Abstract][Full Text] [Related]
39. Insulin resistance: from benign to type 2 diabetes mellitus.
Goldstein BJ
Rev Cardiovasc Med; 2003; 4 Suppl 6():S3-10. PubMed ID: 14668698
[TBL] [Abstract][Full Text] [Related]
40. Nutrition, metabolic factors and cancer risk.
Dossus L; Kaaks R
Best Pract Res Clin Endocrinol Metab; 2008 Aug; 22(4):551-71. PubMed ID: 18971118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
